Who can use Emflaza(Deflazacort)?

This part describes the specific medical condition that EMFLAZA is approved to treat.

Approved Use

EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD). Its use is approved in patients 2 years of age and older. DMD is a genetic disorder characterized by progressive muscle degeneration and weakness. The effectiveness of EMFLAZA in treating DMD was established in clinical studies involving male pediatric patients with a confirmed diagnosis of the disease.